Antibiotic Therapy in Infectious Diseases

Special Issues

Following special issues within this section are currently open for submissions:

• Multidrug-Resistant Organisms (MDROs) in Solid Organ Transplants and the Use of New Beta-lactam Antibiotics (Deadline: 30 April 2024)
• Pulmonary Infections: Pathogenesis and Antimicrobial Treatment (Deadline: 30 April 2024)
• Sepsis Management and Antibiotic Therapy (Deadline: 30 April 2024)
• Antibacterial Treatment in Periodontal and Endodontic Therapy, 2nd Volume (Deadline: 15 May 2024)
• Clinical Impact of Bacterial Resistance: Detection, Infection Control and Antimicrobial Stewardship Solutions (Deadline: 31 May 2024)
• Epidemiology, Diagnosis and Antimicrobial Treatment of Hospital-Acquired Infections (Deadline: 31 May 2024)
• Therapeutic and Microbiological Approaches for Combating Non-tuberculous Mycobacterial Infections (Deadline: 31 May 2024)
• Antimicrobial Therapy in Oral Diseases (Deadline: 31 May 2024)
• The Emergence of Drug-Resistant Staphylococcus aureus Infection and Recent Advances in Treatment Options (Deadline: 1 June 2024)
• Healthcare-Associated Infections (HAIs): Prevention, Control and Surveillance (Deadline: 15 June 2024)
• Present and Future of Antibiotic Treatment for Carbapenem-Resistant Enterobacteriaceae (Deadline: 20 June 2024)
• Carbapenemases in Gram-Negative Bacteria: A Global Health Threat and Therapeutic Challenge (Deadline: 30 June 2024)
• Optimizing Antibiotics Therapy for Combating Difficult-to-Treat Infections by Multidrug-Resistant Gram-Negative Bacteria (Deadline: 30 June 2024)
• Antimicrobial Treatment of Lower Respiratory Tract Infections (Deadline: 30 June 2024)
• Antibiotics and Infectious Respiratory Diseases, 2nd Volume (Deadline: 1 July 2024)
• Carbapenem Resistant Gram-Negative Pathogens—a Comprehensive Approach to Acinetobacter, Pseudomonas, Enterobacteriaceae, and Stenotrophomonas: A Global Healthcare Threat (Deadline: 15 July 2024)
• ‘Non-traditional’ Antimicrobial Approaches to Combat Antimicrobial Resistance (Deadline: 15 July 2024)
• Antibiotics in Ophthalmology Practice (Deadline: 15 July 2024)
• Feature Papers in Therapy of Diabetic Foot Infections (Deadline: 15 July 2024)
• Antimicrobial Resistance and Therapy in Intensive Care Unit (Deadline: 31 July 2024)
• Gastroenterology: The Pathogenic Potential of Mycobacterium paratuberculosis and Emerging Treatment Targets to Address Increasing Resistance (Deadline: 31 July 2024)
• A Themed Issue in Honor of Professor Robert A. Bonomo—Outstanding Contributions in the Fields of ß-Lactamase Inhibitors (Deadline: 31 July 2024)
• Evolution of Antimicrobial Resistance and Implications for Therapy in Respiratory Infections (Deadline: 31 July 2024)
• Approaches to Navigating Multi-Drug Resistance in Gram-Negative Pathogens (Deadline: 31 July 2024)
• Diagnosis and Antimicrobial Therapy of Osteoarticular Infection (Deadline: 31 July 2024)
• Antimicrobial Combination Therapy to Treat Difficult-to-Treat Infections: From Bench to the Bedside (Deadline: 15 August 2024)
• Bacteremia: Clinical Diagnostics and Epidemiology (Deadline: 15 August 2024)
• Antibiotics Prophylaxis for Knee Arthroplasty: Benefits and Problems, 2nd Edition (Deadline: 15 September 2024)
• Advancements in the Control and Diagnosis of Antimicrobial Resistance in Infectious Diseases (Deadline: 15 September 2024)
• Diagnosis and Treatment of Drug-Resistant Mycobacterium tuberculosis (Deadline: 15 September 2024)
• Emerging Topics in Clostridioides difficile Infection: A One Health Problem (Deadline: 20 September 2024)
• Epidemiology, Clinical Microbiology and Antimicrobial Therapy: A Shared Effort Against Infectious Diseases (Deadline: 20 September 2024)
• Surgical Infections and Sepsis: Epidemiology, Prevention and Antimicrobial Chemotherapy (Deadline: 30 September 2024)
• Infection Diagnostics and Antimicrobial Therapy for Critical Patient (Deadline: 30 September 2024)
• Epidemiology of Pathogens and Antimicrobial Resistance (Deadline: 30 September 2024)
• One-Stage Revision Arthroplasty: Local Antibacterial Implant Protection Techniques, Antibiotics, and Surgical Treatments (Deadline: 31 October 2024)
• Prevention and Antibiotic Treatment of Periprosthetic Joint Infection (Deadline: 31 October 2024)
• Pathogenesis, Diagnosis and Treatment of H. pylori Infection (Deadline: 31 October 2024)
• Infections in Immunocompromised Hosts and Antimicrobial Therapy (Deadline: 31 October 2024)
• Antimicrobial Therapeutics for Bone and Periprosthetic Joint Infection (Deadline: 31 October 2024)
• Therapeutic Handling of Infections Caused by Difficult-to-Treat Resistance (DTR) Gram-Negative Bacterial Pathogens: Is It Feasible? (Deadline: 18 November 2024)
• Infection and Treatment of Antibiotic-Resistant ESKAPE Pathogens (Deadline: 20 March 2025)